What can we do today in CMPA to reduce future allergic manifestations?

This roundtable, kindly sponsored by Mead Johnson, will examine how prevention and early action can reduce time to diagnosis, avoid unnecessary prescribing, and improve growth and well-being outcomes for children presenting with CMPA. The discussion will focus on the health system impact of consistent, evidence-based pathways, including how integrated neighbourhood teams can support earlier recognition of both IgE and non-IgE presentations, effective safety-netting, and timely access to dietetic care.